Noninvasive assessment of liver fibrosis in patients with chronic hepatitis virus C;Évaluation non invasive de la fibrose hépatique au cours des hépatites chroniques virales C

Presse Medicale

Volumn 35, Issue 9 II, 2006, Pages 1317-1326

  Guéchot, Jérôme ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BIOLOGICAL MARKER; HYALURONIC ACID; METALLOPROTEINASE; PROCOLLAGEN;

ANALYTIC METHOD; BASEMENT MEMBRANE; BIOASSAY; BLOOD COMPONENT; CELL METABOLISM; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL INDICATOR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ELASTOGRAPHY; ENZYME MECHANISM; EQUIPMENT; EXTRACELLULAR FLUID; FIBROGENESIS; HEPATITIS C; HISTOLOGY; HUMAN; INVASIVE PROCEDURE; LIVER CIRRHOSIS; LIVER FIBROSIS; MEDICAL DECISION MAKING; NON INVASIVE PROCEDURE; PARAMETERS OF MEASUREMENT AND ANALYSIS; PROFESSIONAL KNOWLEDGE; PROGNOSIS; PROTEOMICS; PROTHROMBIN TIME; PUNCH BIOPSY; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SEROLOGY; STANDARD; THROMBOCYTE; DIGESTIVE SYSTEM EXAMINATION; LIVER; NEEDLE BIOPSY; PATHOLOGY;

BIOLOGICAL MARKERS; BIOPSY, NEEDLE; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS;

EID: 33748674220     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(06)74811-4     Document Type: Review

References (45)

1. Bedossa P, Poynard T. An algorithm for grading of activity in chronic hepatitis C. Hepatology. 1996; 24: 289-93.
2. Nousbaum JB. Place de la ponction-biopsie hépatique dans la prise en charge de l'hépatite chronique C. Gastroenterol Clin Biol. 2002; 26: 168-73.
3. Cadranel JF, Rufat P, Degos F Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000; 32: 477-81.
4. Rousselet MC, Michalak S, Dupre F, Croué A, Bedossa P, Saint-André JP et al. Source of variability in physiological scoring of chronic viral hepatitis. Hepatology. 2005; 41: 257-64.
5. Nord HU. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques - a review. Gastrointest endosc. 1982; 28: 102-4.
6. Maharaj B, Maharaj BJ, Leary WP, Coopan RM, Naran AD, Pirie D et al. Sampling variability and its influence on the diagnostic yield of percutaneous biopsy of the liver. Lancet. 1986; 1: 523-5.
7. Regev A, Berho M, Jeffers LJ Milikowski C, Molina EG, Pyrsopoulos NT et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002; 97: 2614-8.
8. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003; 38: 1449-57.
9. The French Metavir Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994; 20: 15-20.
10. Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG et al. Role of liver biopsy in management of chronic hepatitis C: a systemetic review. Heptology. 2002; 36: S161-S172.
11. Croquet V, Vuillemin E, Ternisien C, Pilette C, Orbeti F, Gallois Y et al. Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol. 2002; 14: 1133-41.
12. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aubé C et al. Non invasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology. 1997; 113: 1609-16.
13. Plebani M, Burlina A. Biochemical markers of hepatic fibrosis. Clin Biochem. 1991; 24: 219-39.
14. Guéchot J, Poupon RE, Poupon R. Serum hyaluronan as a marker of liver fibrosis. J Hepatol. 1995; 22: 103-6.
15. Guéchot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen aminoterminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC analysis. Clin Chem. 1996; 42: 558-63.
16. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral hepatitis. 1998; 5: 187-92.
17. Halfon P, Bourlière M, Pénaranda G, Deydier R, Renou C, Botta-Fridlund D et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comparative Hepatology. 2005; 4: 6.
18. Guéchot J, Serfaty L, Bonnand AM, Chazouillères O, Poupon RE, Poupon R, Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol. 2000; 32: 447-52.
19. Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology. 1994; 20: 780-7.
20. Kasahara A, Hayashi N, Mochizuki K, Oshita M, Katayama K, Kato M et al. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response. J Hepatol. 1997; 26: 574-83.
21. Imbert-Bismuth F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poinard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001: 357; 1069-75.
22. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology. 2003; 38: 481-92.
23. Myers RP, De Torres M, Imbert-Bismut F, Ratziu V, Charlotte F, Poynard T. Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index. Dig Dis Sci. 2003; 48: 146-53.
24. Poynard T, Zoulim F, Ratziu V, Degos F, Imbert-Bismut f, Deny P et al. Longitudinal assessment of histology surrogate markers (Fibrotest - Actitest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gastroenterol. 2005; 100: 1970-80.
25. Poynard T, Imbert-Bismuth F, Munteanu M, Messous D, Myers RP, Thabut D et al. Overview of the diagnostic value of biochemeical markers of fibrosis (Fibrotest, HCV Fibrosure) and necrosis (Actitest) in patients with chronic hepatitis C. Comparative Hepatology. 2004; 3: 8.
26. Castera L., Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M et al. Prospective comparison of transcient elastography, Fibrotest, APRI, and liver biopsy for the assement of fibrosis in chronic hepatitis C. Gastroenterology. 2005; 128: 343-50.
27. Callewaert N, Van Vlierberghe H, Van Hecke A, Van Hecke A, Laroy W, Delanghe J et al. Noninvasive diagnosis of liver cirrhosis using DNA seguencer based total serum protein glycomics. Nat Med. 2004; 10: 429-34.
28. Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G et al. Validation of the Fibrotest biochemical markers score in assessing liver fibrosis in hepatitis C patient. Clin Chem. 2003; 49: 450-4.
29. Thuluvath PJ, Krok KL. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol. 2005; 100: 1981-3.
30. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quintó L, Martinez-Bauer E et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002; 36: 986-92.
31. Wai CT, Greeson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38: 518-26.
32. Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C et al. Comparison and validation of simple non-invasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005; 41: 1376-82.
33. Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: Comparison with PIIINP and Hyaluronic Acid. Am J Gastroenterol. 2004; 99: 271-9.
34. Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol. 2004; 41: 935-42.
35. Sud A, Hui JM, Farrel GC et al. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology. 2004; 39: 1239-47.
36. Rosenberg WMC, Voelker M., Thiel R, Becka M, Burt A, Schuppan D et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology. 2004; 127: 1704-13.
37. Adams LA, Bulsara M, Rossi E et al. Hepascore: An accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005; 51: 1867-73.
38. Calès P, Oberti, F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005; 42: 1373-81.
39. Poon TC, Hui AY, Chan HLY Ang IL, Chow SM, Wong N et al. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B Infection by Serum Proteomic Fingerprinting: A Pilot Study. Clin. Chem. 2005; 51: 328-35
40. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003; 29: 1705-13.
41. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005; 41: 48-54.
42. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42; 838-45.
43. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X et al. Diagnosis of cirrhosis by transient elastography (Fibroscan⋯): a prospective study. Gut. 2006; 55: 403-8.
44. Myara A, Guéchot J, Imbert-Bismut F, Lasnier E, Piton A, Voitot H et al. Harmonization of liver enzyme results: calibration for aminotransferases and gammaglutamyltransferase. J Hepatol. 2004; 41: 501-2.
45. Rosenthal-Allieri MA, Peritore ML, Tran A, Halphon P, Benzaken S, Bernard A. Analytical variability of the fibrotest proteins. Clin Biochem. 2005; 38: 473-8.